Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab plus glucocorticoid in pretreated elderly CLL
2010-023205-35Phase 2Completed
- Sponsor
- Vilnius University Hospital Santaros Klinikos
- Start
- Oct 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of rituximab in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), sponsored by Vilnius University Hospital Santaros Klinikos. Primary endpoint: Overall response rate. Started Oct 2010; status: completed.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
Beyond the preview
Go deeper on 2010-023205-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023205-35.